Roslund, Kajsa
Uosukainen, Moona
Järvik, Katriin
Hartonen, Kari
Lehto, Markku
Pussinen, Pirkko
Groop, Per-Henrik
Metsälä, Markus
Funding for this research was provided by:
Wilhelm och Else Stockmanns Stiftelse
Alfred Kordelinin Säätiö
Helsingin Yliopisto
Folkhälsanin Tutkimussäätiö
Academy of Finland (275614)
Novo Nordisk Fonden (#NNF OC0013659)
Helsingin ja Uudenmaan Sairaanhoitopiiri
Article History
Received: 13 July 2022
Accepted: 15 December 2022
First Online: 29 December 2022
Competing interests
: PHG has received lecture fees from Astellas, Astra Zeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Medscape, MSD, Mundipharma, Novartis, Novo Nordisk, PeerVoice, Sanofi, and Sciarc. He is an advisory board member for AbbVie, Astellas, Astra Zeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Janssen, Medscape, MSD, Mundipharma, Novartis, Novo Nordisk, and Sanofi. Other authors declare no conflict of interest.